Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06855836 · ClinicalTrials.gov registry record · NA
Motivational Interviewing to Increase Uptake of Drug Checking and Safe Drug Use Behaviors to Reduce Overdose
A NA study of Overdose, sponsored by University of California, San Diego.
- Active
- Registry status
- NA
- Development phase
- 588
- Enrollment target
- 1
- Study location
NCT06855836: Active NA study of Overdose, sponsored by University of California, San Diego.
NCT06855836 is a NA study of Overdose that is active but no longer recruiting, run by University of California, San Diego. The registered enrollment target is 588 participants, above the 220-participant average among 13 other Overdose trials with a reported enrollment target (167% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06855836, a NA study of Overdose, is active but no longer recruiting, sponsored by University of California, San Diego.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 588 participants
- Enrollment target
- 1
- Study location
Study Summary
A hybrid type 1 study will be conducted to evaluate efficacy and preliminary implementation considerations for a novel intervention to promote uptake of drug checking services (DCS) and safer drug use behaviors among people who use drugs (PWUD) to reduce incidence of overdose (OD) and HIV and Hepatitis C virus (HCV) infections in San Diego County. Along with \~50 other syringe services programs (SSPs) in the US, the Harm Reduction Coalition San Diego (HRCSD), a local SSP, recently launched CheckSD (San Diego), a DCS using test strips (TS) and Fourier Transform Infrared Spectrometry (FTIR) that allows people to submit drug samples with non-nominal identifiers and obtain personalized results. While most existing DCS using FTIR offer some counseling, no theory-based interventions to increase DCS uptake and promote post-DCS adoption of safer drug use behaviors have been rigorously evaluated
Primary Outcome
Rate of fatal and non-fatal ODs over the course of the study (i.e., the total # of ODs that a participant experiences during the study offset by the natural log of the time spent at risk during the study). Self-reported and obtained through record linkage between MI-CHANCE and emergency medical services and the medical examiner's office to obtain data on ODs that received medical attention and OD deaths, respectively
Conditions Studied
Interventions
- BEHAVIORAL MI-CHANCE (TS + FTIR + MI)
- BEHAVIORAL TS + FTIR + Flu and Hepatitis A Education
Study Locations (1)
California
- MI CHANCE - Park Blvd - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 588 participants |
| Start Date | 2025-03-03 |
| Est. Completion | 2029-05 |
| Phase | NA |
What the registry record for NCT06855836 still lists
NCT06855836 is an interventional study that assigns participants to a tested intervention. The registered 588 participants enrollment target is mid-sized for trials with a published cap, above the 220-participant average among 13 other Overdose trials with a reported enrollment target (167% higher).
The record links to 1 condition, with Overdose appearing as the primary indexed condition, and to 2 interventions - of which MI-CHANCE (TS + FTIR + MI) is the first listed.
NCT06855836 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06855836 about?
NCT06855836 is a clinical study titled "Motivational Interviewing to Increase Uptake of Drug Checking and Safe Drug Use Behaviors to Reduce Overdose". A hybrid type 1 study will be conducted to evaluate efficacy and preliminary implementation considerations for a novel intervention to promote uptake of drug checking services (DCS) and safer drug use behaviors among people who use drugs (PWUD) to reduce incidence of overdose (OD) and HIV and Hepati...
What is the current status of trial NCT06855836?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 588 participants. The study started on 2025-03-03. Estimated completion is 2029-05.
What conditions does trial NCT06855836 study?
This clinical trial studies the following conditions: Overdose.
What interventions are being tested in trial NCT06855836?
The interventions under investigation include: MI-CHANCE (TS + FTIR + MI) (BEHAVIORAL), TS + FTIR + Flu and Hepatitis A Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT06855836?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06855836 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overdose
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06855836's enrollment target sits among peer trials
588 2nd of 13 the highest of 13 other Overdose trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overdose trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
A Universal Primary Care Based Intervention to Reduce Youth Overdose Risk
RECRUITING · NA
-
The Impact of a Web-Based Naloxone Intervention Under Standing Orders to Patients Prescribed Chronic Opioid Therapy
ACTIVE NOT RECRUITING · NA
-
The Ganchero Intervention for Migrant People Who Inject Drugs From Puerto Rico in New York City
ACTIVE NOT RECRUITING · NA
-
Improving Access to Naloxone to Prevent Opioid Overdose Deaths (SAIA-Naloxone)
ACTIVE NOT RECRUITING · NA
-
Evaluation of a Medication Health Center to Promote Opioid Safety
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06921603 · 588 participants · NA
POCUS-Guided Diuresis for Decompensated Heart Failure
- NCT06986954 · 588 participants
Beacon Tip Sizing Catheter and Slip-Cath Beacon Tip Catheter Study
- NCT01365169 · 590 participants · NA
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
- NCT03774758 · 590 participants
Biomarkers for Risk Stratification in Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI